S,S′-dinitrosobucillamine, a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

S,S′-dinitrosobucillamine, a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols

Published:2014-05 Issue: Volume:730 Page:171-179
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Dahboul Fatima,Perrin-Sarrado Caroline,Boudier Ariane,Lartaud Isabelle^ORCID,Schneider Raphaël,Leroy Pierre

Publisher

Elsevier BV

Subject

Pharmacology

Reference37 articles.

1. S-nitrosothiols as nitric oxide-donors: chemistry, biology and possible future therapeutic applications;Al-Sa׳doni;Curr. Med. Chem.,2004

2. A novel family of S-nitrosothiols: chemical synthesis and biological actions;Al-Sa׳doni;Nitric Oxide Biol. Chem.,2000

3. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries;Alencar;J. Pharmacol. Exp. Ther.,2003

4. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury;Amersi;Proc. Natl. Acad. Sci. U.S.A.,2002

5. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations;Arnold;Proc. Natl. Acad. Sci. U.S.A.,1977

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Bucillamine as anti-COVID-19 drug: DFT study, molecular docking, molecular dynamic simulation and ADMET analysis;Journal of Biomolecular Structure and Dynamics;2023-03-30

2. S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction;Biochemical Pharmacology;2020-03

3. Biological control ofS-nitrosothiol reactivity: potential role of sigma-hole interactions;Physical Chemistry Chemical Physics;2020

4. In vivo and in silico evaluation of a new nitric oxide donor, S,S′ -dinitrosobucillamine;Nitric Oxide;2017-12

5. The latest advances in the discovery of nitric oxide hybrid drug compounds;Expert Opinion on Drug Discovery;2017-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3